Morris Laster

Morris Laster

Medical Venture Partner, OurCrowd

ABOUT

Dr. Morris Laster is a healthcare executive/entrepreneur with close to 30 years of experience in the biopharmaceutical industry. His expertise lies in the identification, development, management and financing of advanced biomedical drugs and technologies. Morris is Medical Venture Partner at OurCrowd (www.ourcrowd.com) where he has led 23 investments. He is an OurCrowd Board member of HiL, BrainQ and Dreamed. He is a Co-Chairman and CEO of Scopus Biopharmaceuticals Inc, a company specializing in developing novel synthetic cannabinoids. Additionally he serves as the Chairman of Oncohost as well as a board member at Biondvax (NASDAQ:BVXV). He has founded 6 companies that have gone public in the US, UK and Israel. He was a co-founder and CEO of Kitov Pharmaceuticals that has recently FDA approval for its drug called Consensi. Previously, (2003-2009) he was the founding CEO of BioLineRx Ltd. (TASE:BLRX). From 1997-2002 he was the Chairman and CEO of Keryx Biopharmaceuticals (NASDAQ:KERX). He began his career as a VP of medical venture capital at Paramount Capital in NYC. He received his MD from Downstate Medical Center, Brooklyn, NY in 1990 and a BS in Biology from SUNY Albany